跳至主要内容
临床试验/CTRI/2022/03/040892
CTRI/2022/03/040892招募中3 期

iacinamide and renal recovery in community acquired AKI: feasibility study

Department of Nephrolog0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age between 18 â?? 70 years
  • Diagnosis of community-acquired AKI

排除标准

  • Pre-existing CKD with baseline CKD EPI eGFR <60ml/min/1.73m2 prior to the onset of illness.
  • High likelihood of underlying CKD as determined by treating physician based on clinical and laboratory parameters.
  • Suspected or biopsy proven glomerulonephritis as a cause of AKI.
  • Obstructive nephropathy as a cause of AKI.
  • Solid-organ or bone marrow transplant recipients.
  • High likelihood of re-hospitalization or death in the following 4 months as ascertained by treating physician.
  • Suspected or diagnosed case of decompensated chronic liver disease or AST/ ALT more than 5 times of upper limit of normal.
  • Suspected or diagnosed case of heart failure with functional class 3 or 4.
  • Past or present diagnosis of malignancy.

研究者

发起方
Department of Nephrolog

相似试验